UNITED THERAPEUTICS Corp (UTHR) stock
UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3025% above fair value
$591.17−2.14 (-0.36%)
Close on Nov 13, 2026Market cap $25.36BP/E 22.3Yield –
United Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
United Therapeutics's operating margin for the twelve months ending Sep 30, 2026 was 41.4%. For fiscal 2025 it was 46.9%, against 47.9% the year before. The highest annual figure on record is 66.4% in fiscal 2016.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 46.9% | −1.0 |
| FY2024 | Dec 31, 2024 | 47.9% | −3.1 |
| FY2023 | Dec 31, 2023 | 50.9% | +0.3 |
| FY2022 | Dec 31, 2022 | 50.6% | +17.6 |
| FY2021 | Dec 31, 2021 | 33.0% | −7.0 |
| FY2020 | Dec 31, 2020 | 40.0% | +53.0 |
| FY2019 | Dec 31, 2019 | -12.9% | −62.4 |
| FY2018 | Dec 31, 2018 | 49.5% | +2.2 |
| FY2017 | Dec 31, 2017 | 47.2% | −19.2 |
| FY2016 | Dec 31, 2016 | 66.4% | +18.7 |
| FY2015 | Dec 31, 2015 | 47.7% | +5.9 |
| FY2014 | Dec 31, 2014 | 41.8% | +15.6 |
| FY2013 | Dec 31, 2013 | 26.2% | −19.8 |
| FY2012 | Dec 31, 2012 | 46.0% | +3.3 |
| FY2011 | Dec 31, 2011 | 42.8% | +13.9 |
| FY2010 | Dec 31, 2010 | 28.9% | +21.7 |
| FY2009 | Dec 31, 2009 | 7.2% | +36.3 |
| FY2008 | Dec 31, 2008 | -29.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 37.0% | −11.6 |
| Q2 FY2026 | Jun 30, 2026 | 42.2% | −3.4 |
| Q1 FY2026 | Mar 31, 2026 | 41.7% | −6.5 |
| Q4 FY2025 | Dec 31, 2025 | 45.1% | −3.5 |
| Q3 FY2025 | Sep 30, 2025 | 48.6% | +2.8 |
| Q2 FY2025 | Jun 30, 2025 | 45.6% | +0.9 |
| Q1 FY2025 | Mar 31, 2025 | 48.2% | −4.4 |
| Q4 FY2024 | Dec 31, 2024 | 48.6% | +6.3 |
| Q3 FY2024 | Sep 30, 2024 | 45.8% | −7.8 |
| Q2 FY2024 | Jun 30, 2024 | 44.7% | −7.8 |
| Q1 FY2024 | Mar 31, 2024 | 52.6% | −3.5 |
| Q4 FY2023 | Dec 31, 2023 | 42.3% | +6.6 |
| Q3 FY2023 | Sep 30, 2023 | 53.7% | −7.3 |
| Q2 FY2023 | Jun 30, 2023 | 52.5% | +9.3 |
| Q1 FY2023 | Mar 31, 2023 | 56.1% | −6.2 |
| Q4 FY2022 | Dec 31, 2022 | 35.7% | −5.2 |
| Q3 FY2022 | Sep 30, 2022 | 60.9% | +9.5 |
| Q2 FY2022 | Jun 30, 2022 | 43.2% | −6.5 |
| Q1 FY2022 | Mar 31, 2022 | 62.4% | +79.4 |
| Q4 FY2021 | Dec 31, 2021 | 40.9% | +23.9 |
| Q3 FY2021 | Sep 30, 2021 | 51.4% | −6.7 |
| Q2 FY2021 | Jun 30, 2021 | 49.8% | +11.0 |
| Q1 FY2021 | Mar 31, 2021 | -17.1% | −63.9 |
| Q4 FY2020 | Dec 31, 2020 | 17.0% | −3.4 |
| Q3 FY2020 | Sep 30, 2020 | 58.2% | +12.5 |
| Q2 FY2020 | Jun 30, 2020 | 38.8% | −20.4 |
| Q1 FY2020 | Mar 31, 2020 | 46.8% | +227.7 |
| Q4 FY2019 | Dec 31, 2019 | 20.4% | −14.1 |
| Q3 FY2019 | Sep 30, 2019 | 45.7% | +9.4 |
| Q2 FY2019 | Jun 30, 2019 | 59.3% | +10.4 |
| Q1 FY2019 | Mar 31, 2019 | -180.9% | −259.7 |
| Q4 FY2018 | Dec 31, 2018 | 34.5% | +4.6 |
| Q3 FY2018 | Sep 30, 2018 | 36.2% | −36.4 |
| Q2 FY2018 | Jun 30, 2018 | 48.9% | +29.0 |
| Q1 FY2018 | Mar 31, 2018 | 78.9% | +7.7 |
| Q4 FY2017 | Dec 31, 2017 | 29.9% | −12.7 |
| Q3 FY2017 | Sep 30, 2017 | 72.7% | – |
| Q2 FY2017 | Jun 30, 2017 | 19.9% | – |
| Q1 FY2017 | Mar 31, 2017 | 71.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 42.6% | – |
See a number that looks wrong?